Katherine Christian, Carolyn Johnstone, Jo-ann Larkins, Wendy Wright and Michael Doran Katherine Christian, Federation University Australia Carolyn Johnstone, Federation University
Dr Jo-Anne Kelder, Senior Lecturer, Curriculum Innovation and Development, University of Tasmania, https://www.linkedin.com/in/jokelder/ Professor Sue Jones, Honorary Researcher, School of
Professor Jennifer Byrne | University of Sydney Medical School and Children’s Hospital at Westmead At home, I am constantly
“Reminder about service options and an easy way to pay AHRECS,” we say… aware of how corporate sleazy that sounds
Dr Gary Allen, Senior Consultants AHRECS Prof. Mark Israel Prof. Colin Thomson AM . Just in time for the end of the
Prof. Colin Thomson AM, Senior Consultant, AHRECS This news item, while identifying the fact that the decision relates to court proceedings
All Australian research institutions that receive NHMRC or ARC research funding or otherwise operate under the auspices of Universities Australia
Dr Amanda Fernie, Manager Research Ethics & Integrity, Griffith University Dr Gary Allen, Senior Policy Officer, Griffith University AUSTRALIAN CODE
Michael James PhD, Senior Researcher, Rheumatology Unit, Royal Adelaide Hospital Les Cleland AM MBBS MD FRACP, Head of Rheumatology (1982-2015),
After a paper has been through peer review and has been published it is
Gary Allen, Mark Israel and Colin Thomson|
In the 1980s and 1990s, many research institutions made the principled and commendable decision not to accept funding from the tobacco industry.
This reflected the recognition of the awful health impacts of tobacco use and the degree to which the industry was muddying the waters of public debate with academic and clinical research questioning the veracity of the overwhelming body of evidence that clearly showed the dire dangers of activity such as smoking. While we continue to be shocked by cases such those like the research of Hans J Eysenck (and this), for the main it is accepted that receiving funding from the tobacco industry is not in the public’s best interest.
Dr Nathan Emmerich Research Fellow in Bioethics at ANUMS Despite the fact that one
Nik Zeps AHRECS Consultant Clinical trials have enormous value to society as they provide